Drug-drug interactions among elderly patients hospitalized for drug toxicity

被引:520
|
作者
Juurlink, DN
Mamdani, M
Kopp, A
Laupacis, A
Redelmeier, DA
机构
[1] Univ Toronto, Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Clin Epidemiol & Healthcare Res Program, Toronto, ON M4N 3M5, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M4N 3M5, Canada
[4] Univ Toronto, Dept Pharm, Toronto, ON M4N 3M5, Canada
[5] Inst Clin Evaluat Sci, Toronto, ON, Canada
来源
关键词
D O I
10.1001/jama.289.13.1652
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Drug-drug interactions are a preventable cause of morbidity and mortality, yet their consequences in the community are not well characterized. Objective To determine whether elderly patients admitted to hospital with specific drug toxicities were likely to have been,prescribed an interacting drug in the week prior to admission. Design Three population-based, nested case-control studies. Setting Ontario, Canada, from January 1, 1994, to December 31, 2000. Patients All Ontario residents aged 66 years or older treated with glyburide, digoxin, or an angiotensin-converting enzyme (ACE) inhibitor. Case patients were those admitted to hospital for drug-related toxicity. Prescription records of cases were compared with those of controls (matched on age, sex, use of the same medication, and presence or absence of renal disease) for receipt of interacting medications (co-trimoxazole with glyburide, clarithromycin with digoxin, and potassium-sparing diuretics with ACE inhibitors). Main Outcome Measure Odds ratio for association between hospital admission for drug toxicity (hypoglycemia, digoxin toxicity, or hyperkalemia, respectively) and use of an interacting medication in the preceding-week, adjusted for diagnoses, receipt of other medications, the number of prescription drugs, and the number of hospital admissions in the year preceding the index date. Results During the 7-year study period, 909 elderly patients receiving glyburide were admitted with a diagnosis of hypoglycemia. In the primary analysis, those patients admitted for hypoglycemia were more than 6 times as likely to have been treated with co-trimoxazole in the previous week (adjusted odds ratio, 6.6; 95% confidence interval, 4.5-9.7). Patients admitted with digoxin toxicity (n=1051) were about 12 times more likely to have been treated with clarithromycin (adjusted odds ratio, 11.7; 95% confidence interval, 7.5-18.2) in the previous week, and patients treated with ACE inhibitors admitted with a diagnosis of hyperkalemia (n=523) were about 20 times more likely to have been treated with a potassium-sparing diuretic (adjusted odds ratio, 20.3; 95% confidence interval, 13.4-30.7) in the previous week. No increased risk of drug toxicity was found for drugs with similar indications but no known interactions (amoxicillin, cefuroxime, and indapamide, respectively). Conclusions Many hospital admissions of elderly patients for drug toxicity occur after administration of a drug known to cause drug-drug interactions. Many of these interactions could have been avoided.
引用
收藏
页码:1652 / 1658
页数:7
相关论文
共 50 条
  • [31] Prevalence and sort of pharmacokinetic drug-drug interactions in hospitalized psychiatric patients
    Hefner, Gudrun
    Wolff, Jan
    Hahn, Martina
    Hiemke, Christoph
    Toto, Sermin
    Roll, Sibylle C.
    Messer, Thomas
    Klimke, Ansgar
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2020, 127 (08) : 1185 - 1198
  • [32] The Risk of Drug-Drug Interactions with Paracetamol in a Population of Hospitalized Geriatric Patients
    Kaas Oldenburg, Lykke Ida
    Dalhoff, Kim Peder
    Sandoval, Luana Osterdal
    Vermehren, Charlotte
    [J]. JOURNAL OF PHARMACEUTICS, 2020, 2020
  • [33] Impact of Drug-Drug Interactions on Compliance among Elderly Antidepressant Users
    Mark, Tami L.
    Joish, Vijay N.
    Hay, Joel
    Sheehan, David
    Choi, C. J.
    Johnston, Stephen
    Zhun, Cao
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S94 - S95
  • [34] Drug-drug interactions and potentially inappropriate medications among elderly outpatients
    Fatemeh, Atrianfar
    Fatemeh, Rezaei
    Kazem, Heidari
    Mona, Kargar
    Reza, Javadi Mohammad
    Kheirollah, Gholami
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 57
  • [35] Impact of Drug-Drug Interactions on Compliance among Elderly Antidepressant Users
    Joish, Vijay
    Mark, Tami L.
    Johnston, Stephen S.
    Cao, Zhun
    Choi, Jiyoon C.
    Hay, Joel W.
    Sheehan, David V.
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 17 (03): : A98 - A99
  • [36] Clinically relevant drug-drug interactions among elderly people with dementia
    Sonnerstam, Eva
    Sjolander, Maria
    Lovheim, Hugo
    Gustafsson, Maria
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (10) : 1351 - 1360
  • [37] Warfarin toxicity caused by drug-drug interactions
    van Antwerpen, Monet
    [J]. SA PHARMACEUTICAL JOURNAL, 2022, 89 (04) : 40 - 42
  • [38] NIMODIPINE - POTENTIAL FOR DRUG-DRUG INTERACTIONS IN THE ELDERLY
    MUCK, W
    AHR, G
    KUHLMANN, J
    [J]. DRUGS & AGING, 1995, 6 (03) : 229 - 242
  • [39] Sunscreen ingredients in plasma: a threat for drug-drug interactions and toxicity among patients living with HIV?
    Maggi, Paolo
    Brancaccio, Giuseppina
    Gaeta, Giovanni B.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (10) : 775 - 778
  • [40] Polypharmacy and drug-drug interactions among patients with ulcerative colitis
    Esteban, Figueroa
    Overby, M.
    Brian, Behm
    Takahiro, Nakamura
    Brian, Wentworth
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S25 - S26